Severe Thrombocytopenia in a Patient with COVID-19

Eliel Nham1, Jae Hoon Ko1, Byeong Ho Jeong2

  • 1Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Insights

This case study highlights a severe drop in platelet count in a COVID-19 patient treated with multiple drugs. Discontinuing ceftriaxone, levofloxacin, and lopinavir/ritonavir led to platelet recovery, suggesting potential drug-induced thrombocytopenia.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Hematology

Background:

  • The global spread of Coronavirus disease 2019 (COVID-19) necessitates urgent treatment strategies.
  • Empirical antibacterial and antiviral therapies are commonly used due to incomplete understanding of COVID-19's clinical features and potential co-infections.
  • Polypharmacy is frequently employed in managing severe COVID-19 cases.

Observation:

  • A patient with COVID-19 developed severe thrombocytopenia, characterized by epistaxis and petechiae.
  • The patient was concurrently treated with ceftriaxone, levofloxacin, and lopinavir/ritonavir.
  • Platelet count dropped critically to 2,000/mm³.

Findings:

  • Discontinuation of the three suspect medications (ceftriaxone, levofloxacin, lopinavir/ritonavir) resulted in the recovery of the patient's platelet count.
  • This suggests a potential link between the combination of these drugs and the observed severe thrombocytopenia.

Implications:

  • While empirical treatment is crucial for emerging infectious diseases like COVID-19, careful consideration of potential adverse drug effects is essential.
  • This case underscores the importance of monitoring for drug-induced thrombocytopenia in patients receiving multiple medications.
  • Further investigation into the safety profile of combined antibiotic and antiviral therapies in COVID-19 patients is warranted.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
211
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.9K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
148
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.8K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
117
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
190